Financhill
Buy
60

CAR Quote, Financials, Valuation and Earnings

Last price:
$106.42
Seasonality move :
5.26%
Day range:
$99.60 - $109.14
52-week range:
$54.03 - $132.25
Dividend yield:
0%
P/E ratio:
8.19x
P/S ratio:
0.34x
P/B ratio:
--
Volume:
1.3M
Avg. volume:
1.8M
1-year change:
-13.91%
Market cap:
$3.7B
Revenue:
$11.6B
EPS (TTM):
-$62.95
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $5.6B $9.7B $13B $12.7B $11.6B
Revenue Growth (YoY) -39.93% 74.02% 34.52% -2.68% -8.23%
 
Cost of Revenues $1.8B $1.9B $2.2B $3.1B $3.8B
Gross Profit $3.7B $7.8B $10.8B $9.5B $7.9B
Gross Profit Margin 66.85% 80.66% 82.72% 75.28% 67.73%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $703M $1.1B $1.3B $1.4B $1.4B
Other Inc / (Exp) -$130M -$205M -$20M -$24M -$2.5B
Operating Expenses $4.3B $5.7B $6.9B $7.3B $7.6B
Operating Income -$595M $2.1B $3.9B $2.2B $269M
 
Net Interest Expenses $231M $218M $250M $296M $358M
EBT. Incl. Unusual Items -$956M $1.7B $3.6B $1.9B -$2.6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$272M $425M $880M $279M -$810M
Net Income to Company -$684M $1.3B $2.8B $1.6B -$1.8B
 
Minority Interest in Earnings -- $2M $8M -$3M -$4M
Net Income to Common Excl Extra Items -$684M $1.3B $2.8B $1.6B -$1.8B
 
Basic EPS (Cont. Ops) -$9.71 $19.79 $58.41 $42.57 -$51.23
Diluted EPS (Cont. Ops) -$9.71 $19.44 $57.16 $42.08 -$51.23
Weighted Average Basic Share $70.5M $64.9M $47.3M $38.3M $35.5M
Weighted Average Diluted Share $70.5M $66.1M $48.4M $38.8M $35.5M
 
EBITDA $1.8B $4.4B $6.7B $5.7B $1.7B
EBIT -$725M $1.9B $3.9B $2.2B -$2.3B
 
Revenue (Reported) $5.6B $9.7B $13B $12.7B $11.6B
Operating Income (Reported) -$595M $2.1B $3.9B $2.2B $269M
Operating Income (Adjusted) -$725M $1.9B $3.9B $2.2B -$2.3B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $1.4B $2.7B $2.8B $2.5B $2.1B
Revenue Growth (YoY) -19.44% 92.47% 2.63% -10.51% -16.56%
 
Cost of Revenues $378M $491M $648M $836M $931M
Gross Profit $1B $2.2B $2.2B $1.7B $1.2B
Gross Profit Margin 73.4% 82.05% 76.92% 66.72% 55.58%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $182M $283M $324M $325M $308M
Other Inc / (Exp) -$150M -$8M -$2M -$5M -$28M
Operating Expenses $1.1B $1.5B $1.7B $1.7B $1.7B
Operating Income -$39M $756M $472M -$54M -$552M
 
Net Interest Expenses $61M $53M $73M $83M $97M
EBT. Incl. Unusual Items -$250M $695M $397M -$142M -$677M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$80M $168M $85M -$29M -$173M
Net Income to Company -$170M $527M $312M -$113M -$504M
 
Minority Interest in Earnings -- $2M -- -$1M -$1M
Net Income to Common Excl Extra Items -$170M $529M $312M -$114M -$505M
 
Basic EPS (Cont. Ops) -$2.43 $9.96 $7.88 -$3.21 -$14.35
Diluted EPS (Cont. Ops) -$2.43 $9.71 $7.72 -$3.21 -$14.35
Weighted Average Basic Share $69.9M $53.1M $39.6M $35.6M $35.2M
Weighted Average Diluted Share $69.9M $54.5M $40.4M $35.6M $35.2M
 
EBITDA $374M $1.4B $1.3B $866M $431M
EBIT -$189M $748M $470M -$59M -$580M
 
Revenue (Reported) $1.4B $2.7B $2.8B $2.5B $2.1B
Operating Income (Reported) -$39M $756M $472M -$54M -$552M
Operating Income (Adjusted) -$189M $748M $470M -$59M -$580M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $5.2B $11B $13.1B $12.4B $11.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.7B $2B $2.4B $3.3B $3.8B
Gross Profit $3.5B $9B $10.7B $9.1B $7.4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $634M $1.2B $1.4B $1.4B $1.3B
Other Inc / (Exp) -$230M -$63M -$14M -$27M -$2.6B
Operating Expenses $4B $6.1B $7.1B $7.3B $7.6B
Operating Income -$467M $2.9B $3.6B $1.7B -$229M
 
Net Interest Expenses $244M $210M $270M $306M $372M
EBT. Incl. Unusual Items -$941M $2.7B $3.3B $1.4B -$3.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$245M $673M $797M $165M -$954M
Net Income to Company -$696M $2B $2.5B $1.2B -$2.2B
 
Minority Interest in Earnings -- $4M $6M -$4M -$4M
Net Income to Common Excl Extra Items -$696M $2B $2.5B $1.2B -$2.2B
 
Basic EPS (Cont. Ops) -$9.99 $33.01 $56.33 $32.06 -$62.93
Diluted EPS (Cont. Ops) -$10.00 $32.42 $55.20 $31.68 -$62.95
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $1.7B $5.4B $6.6B $5.3B $1.3B
EBIT -$697M $2.9B $3.6B $1.7B -$2.8B
 
Revenue (Reported) $5.2B $11B $13.1B $12.4B $11.2B
Operating Income (Reported) -$467M $2.9B $3.6B $1.7B -$229M
Operating Income (Adjusted) -$697M $2.9B $3.6B $1.7B -$2.8B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $1.4B $2.7B $2.8B $2.5B $2.1B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $378M $491M $648M $836M $931M
Gross Profit $1B $2.2B $2.2B $1.7B $1.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $182M $283M $324M $325M $308M
Other Inc / (Exp) -$150M -$8M -$2M -$5M -$28M
Operating Expenses $1.1B $1.5B $1.7B $1.7B $1.7B
Operating Income -$39M $756M $472M -$54M -$552M
 
Net Interest Expenses $61M $53M $73M $83M $97M
EBT. Incl. Unusual Items -$250M $695M $397M -$142M -$677M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$80M $168M $85M -$29M -$173M
Net Income to Company -$170M $527M $312M -$113M -$504M
 
Minority Interest in Earnings -- $2M -- -$1M -$1M
Net Income to Common Excl Extra Items -$170M $529M $312M -$114M -$505M
 
Basic EPS (Cont. Ops) -$2.43 $9.96 $7.88 -$3.21 -$14.35
Diluted EPS (Cont. Ops) -$2.43 $9.71 $7.72 -$3.21 -$14.35
Weighted Average Basic Share $69.9M $53.1M $39.6M $35.6M $35.2M
Weighted Average Diluted Share $69.9M $54.5M $40.4M $35.6M $35.2M
 
EBITDA $374M $1.4B $1.3B $866M $431M
EBIT -$189M $748M $470M -$59M -$580M
 
Revenue (Reported) $1.4B $2.7B $2.8B $2.5B $2.1B
Operating Income (Reported) -$39M $756M $472M -$54M -$552M
Operating Income (Adjusted) -$189M $748M $470M -$59M -$580M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $692M $534M $570M $555M $534M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $647M $775M $810M $900M $838M
Inventory -- -- -- -- --
Prepaid Expenses $161M $205M $252M $239M $239M
Other Current Assets $148M $95M $112M $253M $236M
Total Current Assets $1.8B $1.8B $1.9B $2.1B $2B
 
Property Plant And Equipment $11.1B $15.6B $18.6B $23.9B $20.8B
Long-Term Investments $667M $842M $1.1B $1.3B $1.4B
Goodwill $1.1B $1.1B $1.1B $1.1B $1.1B
Other Intangibles $774M $724M $666M $670M $601M
Other Long-Term Assets $596M $636M $809M $1.2B $976M
Total Assets $17.5B $22.6B $25.9B $32.6B $29B
 
Accounts Payable $394M $407M $466M $487M $450M
Accrued Expenses $239M $411M $473M $605M $564M
Current Portion Of Long-Term Debt $19M $19M $27M $32M $20M
Current Portion Of Capital Lease Obligations $514M $496M $555M $576M $628M
Other Current Liabilities $602M $577M $619M $540M $604M
Total Current Liabilities $2.1B $2.4B $2.6B $2.7B $2.7B
 
Long-Term Debt $11B $15.4B $18.5B $23.7B $22.9B
Capital Leases -- -- -- -- --
Total Liabilities $17.7B $22.8B $26.6B $32.9B $31.4B
 
Common Stock $1M $1M $1M $1M $1M
Other Common Equity Adj -- -- -- -- --
Common Equity -$155M -$220M -$703M -$349M -$2.3B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- $11M $3M $6M $10M
Total Equity -$155M -$209M -$700M -$343M -$2.3B
 
Total Liabilities and Equity $17.5B $22.6B $25.9B $32.6B $29B
Cash and Short Terms $692M $534M $570M $555M $534M
Total Debt $11.1B $15.4B $18.5B $23.8B $22.9B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $576M $550M $548M $522M $516M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $786M $779M $801M $1B $873M
Inventory -- -- -- -- --
Prepaid Expenses $204M $246M $274M $312M $174M
Other Current Assets $163M $87M $161M $246M $231M
Total Current Assets $1.9B $1.8B $2B $2.3B $2B
 
Property Plant And Equipment $12.1B $16.8B $20.1B $25B $21.2B
Long-Term Investments $666M $953M $1.1B $1.3B $1.4B
Goodwill $1.1B $1.1B $1.1B $1.1B $1.1B
Other Intangibles $750M $706M $659M $658M $598M
Other Long-Term Assets $465M $567M $717M $949M $692M
Total Assets $18.6B $23.6B $27.4B $33.5B $29B
 
Accounts Payable $458M $513M $510M $504M $499M
Accrued Expenses $260M $423M $476M $431M $571M
Current Portion Of Long-Term Debt $19M $27M $34M $405M $508M
Current Portion Of Capital Lease Obligations $519M $536M $533M $558M $627M
Other Current Liabilities $569M $656M $627M $651M $613M
Total Current Liabilities $2.2B $2.7B $2.7B $3.1B $3.4B
 
Long-Term Debt $12.1B $16.8B $19.4B $24.2B $22.7B
Capital Leases -- -- -- -- --
Total Liabilities $18.9B $24.6B $27.8B $34B $31.9B
 
Common Stock $1M $1M $1M $1M $1M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- $9M $3M $7M $11M
Total Equity -$316M -$983M -$441M -$508M -$2.8B
 
Total Liabilities and Equity $18.6B $23.6B $27.4B $33.5B $29B
Cash and Short Terms $576M $550M $548M $522M $516M
Total Debt $12.1B $16.8B $19.5B $24.6B $23.2B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$684M $1.3B $2.8B $1.6B -$1.8B
Depreciation & Amoritzation $2.6B $2.5B $2.8B $3.5B $4B
Stock-Based Compensation $9M $30M $25M $30M $19M
Change in Accounts Receivable $115M -$143M -$97M -$43M $51M
Change in Inventories -- -- -- -- --
Cash From Operations $691M $3.5B $4.7B $3.8B $3.5B
 
Capital Expenditures $5.5B $10.2B $10.7B $15.5B $10.1B
Cash Acquisitions -- -- -- -- --
Cash From Investing $3.2B -$6.3B -$4.3B -$7.3B -$2.8B
 
Dividends Paid (Ex Special Dividend) -- -- -- -$355M --
Special Dividend Paid
Long-Term Debt Issued $14.5B $15.6B $18.1B $24.9B $22.9B
Long-Term Debt Repaid -$18.4B -$11.4B -$15.2B -$20B -$23.5B
Repurchase of Common Stock -$119M -$1.5B -$3.3B -$951M -$70M
Other Financing Activities -$44M -$11M $6M -$66M -$72M
Cash From Financing -$4B $2.7B -$360M $3.5B -$781M
 
Beginning Cash (CF) $900M $765M $626M $642M $644M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$177M -$128M $48M -$12M -$16M
Ending Cash (CF) $765M $626M $642M $644M $597M
 
Levered Free Cash Flow -$4.8B -$6.7B -$6B -$11.6B -$6.5B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$170M $527M $312M -$113M -$504M
Depreciation & Amoritzation $563M $633M $784M $925M $1B
Stock-Based Compensation $4M $6M $8M $7M $6M
Change in Accounts Receivable -$56M $167M $100M -$8M $40M
Change in Inventories -- -- -- -- --
Cash From Operations $336M $1.1B $819M $589M $619M
 
Capital Expenditures $3B $2.8B $3.9B $4.1B $3.8B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.4B -$1.2B -$1.7B -$1.5B -$715M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $4.6B $4.7B $5.3B $7.3B $7.4B
Long-Term Debt Repaid -$3.6B -$3.4B -$4.4B -$6.3B -$7.3B
Repurchase of Common Stock -$19M -$1.3B -$51M -$15M -$3M
Other Financing Activities -$12M -$8M -$14M -$47M -$4M
Cash From Financing $914M $30M $841M $897M $98M
 
Beginning Cash (CF) $765M $626M $642M $644M $597M
Foreign Exchange Rate Adjustment -$10M -$2M $5M -$13M $8M
Additions / Reductions -$116M $13M -$18M -$32M $2M
Ending Cash (CF) $639M $637M $629M $599M $607M
 
Levered Free Cash Flow -$2.7B -$1.6B -$3.1B -$3.5B -$3.2B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$696M $2B $2.5B $1.2B -$2.2B
Depreciation & Amoritzation $2.4B $2.6B $3B $3.6B $4.1B
Stock-Based Compensation $15M $32M $27M $29M $18M
Change in Accounts Receivable -$104M $80M -$164M -$151M $99M
Change in Inventories -- -- -- -- --
Cash From Operations $657M $4.3B $4.4B $3.6B $3.5B
 
Capital Expenditures $4.7B $9.9B $11.9B $15.7B $9.7B
Cash Acquisitions -- -- -- -- --
Cash From Investing $3.3B -$6.1B -$4.8B -$7.2B -$2B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $13.5B $15.7B $18.7B $26.9B $23.1B
Long-Term Debt Repaid -$17.5B -$11.2B -$16.1B -$22B -$24.6B
Repurchase of Common Stock -$20M -$2.7B -$2.1B -$915M -$58M
Other Financing Activities -$47M -$7M -- -$99M -$29M
Cash From Financing -$4.1B $1.8B $451M $3.6B -$1.6B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$143M $1M $17M -$26M $18M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$4.1B -$5.6B -$7.5B -$12.1B -$6.2B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$170M $527M $312M -$113M -$504M
Depreciation & Amoritzation $563M $633M $784M $925M $1B
Stock-Based Compensation $4M $6M $8M $7M $6M
Change in Accounts Receivable -$56M $167M $100M -$8M $40M
Change in Inventories -- -- -- -- --
Cash From Operations $336M $1.1B $819M $589M $619M
 
Capital Expenditures $3B $2.8B $3.9B $4.1B $3.8B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.4B -$1.2B -$1.7B -$1.5B -$715M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $4.6B $4.7B $5.3B $7.3B $7.4B
Long-Term Debt Repaid -$3.6B -$3.4B -$4.4B -$6.3B -$7.3B
Repurchase of Common Stock -$19M -$1.3B -$51M -$15M -$3M
Other Financing Activities -$12M -$8M -$14M -$47M -$4M
Cash From Financing $914M $30M $841M $897M $98M
 
Beginning Cash (CF) $765M $626M $642M $644M $597M
Foreign Exchange Rate Adjustment -$10M -$2M $5M -$13M $8M
Additions / Reductions -$116M $13M -$18M -$32M $2M
Ending Cash (CF) $639M $637M $629M $599M $607M
 
Levered Free Cash Flow -$2.7B -$1.6B -$3.1B -$3.5B -$3.2B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Which Stocks Are Recession-Proof?
Which Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Is Gartner a Safe Stock to Own?
Is Gartner a Safe Stock to Own?

Gartner (NYSE:IT) is among the world’s largest consulting, research and…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 44x

Alerts

Buy
57
RGC alert for May 14

Regencell Bioscience Holdings [RGC] is up 15.31% over the past day.

Buy
54
HALO alert for May 14

Halozyme Therapeutics [HALO] is down 4.42% over the past day.

Buy
91
COIN alert for May 14

Coinbase Global [COIN] is up 0.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock